8-Hydroxy-9,10-diisobutyryloxythymolCAS# 22518-08-7 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 22518-08-7 | SDF | Download SDF |
PubChem ID | 16196971 | Appearance | Powder |
Formula | C18H26O6 | M.Wt | 338.39 |
Type of Compound | Terpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | [2-hydroxy-2-(2-hydroxy-4-methylphenyl)-3-(2-methylpropanoyloxy)propyl] 2-methylpropanoate | ||
SMILES | CC1=CC(=C(C=C1)C(COC(=O)C(C)C)(COC(=O)C(C)C)O)O | ||
Standard InChIKey | OQYPKKAXTUWISE-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C18H26O6/c1-11(2)16(20)23-9-18(22,10-24-17(21)12(3)4)14-7-6-13(5)8-15(14)19/h6-8,11-12,19,22H,9-10H2,1-5H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. 8-Hydroxy-9,10-diisobutyryloxythymol shows cytotoxicity on six cancer cell lines (K562, HT-29, SGC-7901, DU145, MDA-MB-231, U251). 2. 8-Hydroxy-9,10-diisobutyryloxythymol may have antibacterial activity. |
Targets | Antifection |
8-Hydroxy-9,10-diisobutyryloxythymol Dilution Calculator
8-Hydroxy-9,10-diisobutyryloxythymol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.9552 mL | 14.7759 mL | 29.5517 mL | 59.1034 mL | 73.8793 mL |
5 mM | 0.591 mL | 2.9552 mL | 5.9103 mL | 11.8207 mL | 14.7759 mL |
10 mM | 0.2955 mL | 1.4776 mL | 2.9552 mL | 5.9103 mL | 7.3879 mL |
50 mM | 0.0591 mL | 0.2955 mL | 0.591 mL | 1.1821 mL | 1.4776 mL |
100 mM | 0.0296 mL | 0.1478 mL | 0.2955 mL | 0.591 mL | 0.7388 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Cathepsin Inhibitor 1
Catalog No.:BCC4896
CAS No.:225120-65-0
- Falcarindiol
Catalog No.:BCN5065
CAS No.:225110-25-8
- IDRA 21
Catalog No.:BCC6974
CAS No.:22503-72-6
- N-(1-hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)acetamide
Catalog No.:BCN1483
CAS No.:2249289-10-9
- Erigeside I
Catalog No.:BCN7172
CAS No.:224824-74-2
- Vardenafil HCl Trihydrate
Catalog No.:BCC2277
CAS No.:224785-90-4
- 18-Norabieta-8,11,13-trien-4-ol
Catalog No.:BCN5064
CAS No.:22478-65-5
- Gymnemagenin
Catalog No.:BCN7841
CAS No.:22467-07-8
- MLCK inhibitor peptide 18
Catalog No.:BCC5828
CAS No.:224579-74-2
- Benfotiamine
Catalog No.:BCC1415
CAS No.:22457-89-2
- Retapamulin
Catalog No.:BCC4837
CAS No.:224452-66-8
- Ginsenoside Rg1
Catalog No.:BCN1066
CAS No.:22427-39-0
- CTU Guanamine
Catalog No.:BCC8921
CAS No.:22535-90-6
- Ocotillone
Catalog No.:BCN5066
CAS No.:22549-21-9
- Robustine
Catalog No.:BCN6653
CAS No.:2255-50-7
- Isocryptotanshinone
Catalog No.:BCN2499
CAS No.:22550-15-8
- Bisabolol Oxide A
Catalog No.:BCC8133
CAS No.:22567-36-8
- Zeorin
Catalog No.:BCN5067
CAS No.:22570-53-2
- Symphytine
Catalog No.:BCN1975
CAS No.:22571-95-5
- PAR 4 (1-6)
Catalog No.:BCC3956
CAS No.:225779-44-2
- Epifriedelanol acetate
Catalog No.:BCN5068
CAS No.:2259-07-6
- Cyclothiazide
Catalog No.:BCC6759
CAS No.:2259-96-3
- (+)-Catechin hydrate
Catalog No.:BCN2309
CAS No.:225937-10-0
- Lucidioline
Catalog No.:BCN7413
CAS No.:22594-91-8
Antibacterial thymol derivatives isolated from Centipeda minima.[Pubmed:17960076]
Molecules. 2007 Jan 27;12(8):1606-13.
Two new monoterpenoids, 8,10-dihydroxy-9(2)-methylbutyryloxythymol (1) and 10-hydroxy-8,9-dioxyisopropylidene-thymol (2), together with five known thymol derivatives: 8,9,10-trihydroxythymol (3), thymol-beta-glucopyranoside (4), 9-hydroxythymol (5), 8,10-dihydroxy-9-isobutyryloxythymol (6), and 8-Hydroxy-9,10-diisobutyryloxythymol (7), were isolated from Centipeda minima. Their structures were identified by means of spectroscopic analyses. Interestingly, compound 2 is not an extraction artifact according to a close HPLC examination of material after extraction by analytical MeOH at ambient temperature. The antibacterial activities of compounds 1-7 were evaluated against eight microbial strains by the agar dilution method.